Bioventus has announced the appointment of Bill Hawkins, retired chairman and chief executive officer (CEO) of Medtronic and currently lead director of Immucor, as its new chairman of the company’s board of managers. Dan Lemaitre, who has served as chairman since the inception of Bioventus in 2012, has decided to leave the company’s board.
“I want to thank Dan Lemaitre for his vision, energy, sage counsel and leadership of our board of managers since Bioventus became a standalone company in 2012. His contributions to our early successes were numerous,” says Tony Bihl, CEO of Bioventus. “As we move into 2016, we are excited to have Bill Hawkins join us to lead our board as chairman. As former CEO of one of the most successful global medical device companies, Bill brings very strong experience in orthobiologics, including BMP, and we look forward to working with him and our Board to continue to grow Bioventus in this space.”
From October 2011 to July 2015, Hawkins served as President and CEO of Immucor, a global provider of transfusion and transplantation diagnostic products. Prior to that, he served as chairman and CEO of Medtronic. Previously, he served as President and CEO of Novoste Corp. Hawkins has also held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corporation, and Eli Lilly & Company.
Hawkins received his bachelor’s degree in electrical and biomedical engineering from Duke University in 1976, where he also conducted medical research in pathology. He then went on to earn an MBA from the Darden School of Business, University of Virginia, in 1982. He is also active on public and private boards as well as non for profit boards.
